Get the Stockscreener App
3.02
3.21%
-0.10
After Hours:
3.02
Maravai Lifesciences Holdings Inc stock is traded at $3.02, with a volume of 1.05M.
It is down -3.21% in the last 24 hours and down -23.35% over the past month.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
See More
Previous Close:
$3.12
Open:
$3.12
24h Volume:
1.05M
Relative Volume:
0.85
Market Cap:
$437.97M
Revenue:
$288.95M
Net Income/Loss:
$-119.03M
P/E Ratio:
-3.3537
EPS:
-0.9005
Net Cash Flow:
$60.67M
1W Performance:
-2.27%
1M Performance:
-23.35%
6M Performance:
+12.27%
1Y Performance:
-29.11%
1-Day Range:
$2.97
$3.17
1-Week Range:
$2.97
$3.21
52-Week Range:
$1.665
$4.40
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Name
Maravai Lifesciences Holdings Inc
Sector
Industry
Phone
(858) 546-0004
Address
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Compare MRVI vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
3.02 | 452.47M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Neutral |
| Dec-05-24 | Downgrade | Goldman | Neutral → Sell |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-13-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-10-24 | Initiated | Craig Hallum | Buy |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-08-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-23-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-09-23 | Downgrade | Goldman | Buy → Neutral |
| Jan-05-23 | Downgrade | UBS | Buy → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Nov-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Dec-16-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-15-20 | Initiated | BofA Securities | Buy |
| Dec-15-20 | Initiated | Credit Suisse | Outperform |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-15-20 | Initiated | Jefferies | Buy |
| Dec-15-20 | Initiated | Robert W. Baird | Outperform |
| Dec-15-20 | Initiated | Stifel | Buy |
| Dec-15-20 | Initiated | William Blair | Outperform |
| Dec-14-20 | Initiated | UBS | Buy |
View All
Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News
Gainers Report: Is Maravai LifeSciences Holdings Incs ROE strong enough2025 Buyback Activity & Smart Swing Trading Techniques - baoquankhu1.vn
Maravai to Announce Q4 and Full Year 2025 Results - Intellectia AI
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 - The Chronicle-Journal
What MACD trends signal for Maravai LifeSciences Holdings Inc. (MAR) stockQuarterly Trade Review & Reliable Breakout Stock Forecasts - mfd.ru
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire
Growth Report: Is Tourmaline Bio Inc a speculative investmentProduct Launch & AI Powered Market Entry Strategies - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect - ACCESS Newswire
Maravai LifeSciences Target of Unusually High Options Trading (NASDAQ:MRVI) - Defense World
Volume Report: How does Maravai LifeSciences Holdings Inc score in quality rankings2025 Market WrapUp & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Tejara Capital Ltd Has $7.04 Million Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Stock Analysis: Is Amylyx Pharmaceuticals Inc stock a buy or sell2025 Technical Overview & Consistent Profit Alerts - baoquankhu1.vn
Maravai LifeSciences Holdings (MRVI): Investor Outlook Amidst A 14.54% Potential Upside - DirectorsTalk Interviews
Market Review: What are CERo Therapeutics Holdings Inc Equity Warrants earnings expectationsJuly 2025 Price Swings & Fast Moving Market Watchlists - baoquankhu1.vn
Aug Mood: Is Maravai LifeSciences Holdings Incs ROE strong enough2025 Valuation Update & Precise Trade Entry Recommendations - baoquankhu1.vn
Maravai LifeSciences Holdings (NASDAQ:MRVI shareholders incur further losses as stock declines 11% this week, taking five-year losses to 90% - simplywall.st
Maravai LifeSciences (NASDAQ:MRVI) Trading Down 8.9%What's Next? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - accessnewswire.com
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Maravai Lifesciences Holdings (MRVI) and CVRx (CVRX) - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat
MRVI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Bear Alert: What is the dividend yield of Maravai LifeSciences Holdings IncRisk Management & Low Risk Growth Stock Ideas - baoquankhu1.vn
Aug Sentiment: Does China Liberal Education Holdings Limited offer margin of safetyJuly 2025 Final Week & Consistent Growth Equity Picks - baoquankhu1.vn
Will Maravai LifeSciences Holdings Inc. stock hit new highs in YEARPortfolio Value Summary & Advanced Technical Signal Analysis - bollywoodhelpline.com
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Maravai LifeSciences (NASDAQ:MRVI) Shares Down 5.8%Should You Sell? - MarketBeat
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus
Maravai LifeSciences (NASDAQ:MRVI) & Capricor Therapeutics (NASDAQ:CAPR) Critical Review - Defense World
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Treasury Yields: Is Maravai LifeSciences Holdings Inc stock oversold or undervaluedRisk Management & Free Growth Oriented Trading Recommendations - Bộ Nội Vụ
Maravai LifeSciences Earnings Call: Mixed Signals - MSN
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q3 Loss, Misses Revenue Estimates - MSN
Can Maravai LifeSciences Holdings Inc. stock withstand economic slowdownWatch List & AI Optimized Trading Strategy Guides - ulpravda.ru
Maravai LifeSciences Holdings (MRVI) Stock Analysis: An Investor’s Guide to Navigating the Biotech Sector - DirectorsTalk Interviews
Why Maravai LifeSciences Holdings Inc. stock is in analyst buy zoneJuly 2025 Sentiment & Weekly High Conviction Ideas - Улправда
How MACOM Technology Solutions Holdings Inc. stock trades during market volatilityJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - ulpravda.ru
Is Maravai LifeSciences Holdings Inc. stock oversold or undervaluedTrade Entry Report & Verified Momentum Stock Ideas - Улправда
Investors Purchase High Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat
Is Maravai LifeSciences Holdings Inc. stock resilient to inflationMACD Trading Signals & Rapid Portfolio Investment - Улправда
How Maravai LifeSciences Holdings Inc. (MAR) stock gains from tech spendingStock Watchlist Updates & Free Trading Psychology Coaching - Улправда
How buybacks impact Maravai LifeSciences Holdings Inc. stock valueEarnings Revision Updates & Identify Winning Stocks - Улправда
Volume Summary: Can Maravai LifeSciences Holdings Inc stock withstand economic slowdownJuly 2025 Analyst Calls & Consistent Profit Alerts - Bộ Nội Vụ
A US$75m Market Cap Boost Pleasing ToMaravai LifeSciences Holdings Insiders - simplywall.st
Maravai LifeSciences (NASDAQ:MRVI) Nasdaq Index Life Sciences Inputs - Kalkine Media
Net current asset value per share of Maravai Lifesciences Holdings, Inc. Class A – SWB:MAR - TradingView — Track All Markets
Maravai LifeSciences (NASDAQ:MRVI) Trading Up 11.3%Time to Buy? - MarketBeat
Ideas Watch: Is Maravai LifeSciences Holdings Inc. stock resilient to inflationMarket Volume Summary & Weekly Stock Performance Updates - Bộ Nội Vụ
Maravai LifeSciences Holdings Inc Stock Analysis and ForecastRSI Overbought/Oversold & Free Superior Trading Gains - earlytimes.in
Critical Analysis: Maravai LifeSciences (NASDAQ:MRVI) versus TerrAscend (OTCMKTS:TSNDF) - Defense World
Maravai Lifesciences Holdings Inc Stock (MRVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):